A carregar...
New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
Certolizumab pegol (CZP) is a new drug from the group of tumor necrosis factor a inhibitors. The efficacy and safety CZP in the treatment of rheumatoid arthritis (RA) have been studied in the international 52-week RAPID-1 and 24-week RAPID-2 clinical trials that studied the use of CZP in combination...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Russo |
Publicado em: |
IMA-PRESS LLC
2012-04-01
|
Colecção: | Научно-практическая ревматология |
Assuntos: | |
Acesso em linha: | https://rsp.mediar-press.net/rsp/article/view/1161 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|